Cargando…

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

BACKGROUND: Breast cancer remains a major health problem worldwide, and is becoming increasingly resistant to traditional drug treatments. For instance, Adriamycin (ADR) is beneficial for the treatment of breast cancer. However, its wide application often leads to drug resistance in clinic practice,...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Ye, Ding, Jie, Lin, Yan, Li, Juan, Shi, Yongguo, Wang, Juan, Zhu, Ya, Wang, Keming, Hu, Xuezhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486132/ https://www.ncbi.nlm.nih.gov/pubmed/26066793 http://dx.doi.org/10.1186/s12906-015-0710-8

Ejemplares similares

Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy
por: Mei, Wang, et al.
Publicado: (2014)

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
por: Chen, Runzhe, et al.
Publicado: (2017)

Gambogenic acid inhibits the proliferation of small-cell lung cancer cells by arresting the cell cycle and inducing apoptosis
por: Huang, Tingting, et al.
Publicado: (2019)

Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells
por: Shen, Daofu, et al.
Publicado: (2020)

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
por: Liu, Ping, et al.
Publicado: (2017)

Gambogenic Acid Induces Endoplasmic Reticulum Stress in Colorectal Cancer via the Aurora A Pathway
por: Liu, Cheng, et al.
Publicado: (2021)

Chemosensitization to adriamycin by cyclosporin A and verapamil in human retinoblastoma cell lines.
por: Lee, T. W., et al.
Publicado: (1993)

Altered gut microbiome promotes proteinuria in mice induced by Adriamycin
por: Jiang, Qian, et al.
Publicado: (2018)

Gambogic acid and gambogenic acid induce a thiol-dependent heat shock response and disrupt the interaction between HSP90 and HSF1 or HSF2
por: Pesonen, Linda, et al.
Publicado: (2021)

The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression
por: Shi, Yongguo, et al.
Publicado: (2015)

Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer--a possible indicator of chemosensitivity.
por: Lee, F. Y., et al.
Publicado: (1989)

Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades
por: Ding, Jie, et al.
Publicado: (2015)

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth
por: Xu, Linfeng, et al.
Publicado: (2018)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy
por: Wang, Na, et al.
Publicado: (2016)

Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers
por: Yang, Libo, et al.
Publicado: (2019)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
por: Cao, Bei, et al.
Publicado: (2013)

The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
por: Wang, Chaokun, et al.
Publicado: (2021)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Altering Chemosensitivity by Modulating Translation Elongation
por: Robert, Francis, et al.
Publicado: (2009)

PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer
por: Chen, Yongxia, et al.
Publicado: (2021)

Analysis of Cardiac Adverse Reactions Caused by Different Doses of Adriamycin Chemotherapy in Patients with Breast Cancer
por: Hu, Guangwen, et al.
Publicado: (2022)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome
por: Lv, Juan, et al.
Publicado: (2023)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
por: Tan, Chunli, et al.
Publicado: (2021)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
por: Sha, Huanhuan, et al.
Publicado: (2022)

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer
por: Ren, Boxue, et al.
Publicado: (2019)

Altered chemosensitivity to CO(2) during exercise
por: Yamashiro, Stanley M., et al.
Publicado: (2021)

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
por: Hayashino, Kenta, et al.
Publicado: (2022)

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

Microribonucleic Acid-15a-5p Alters Adriamycin Resistance in Breast Cancer Cells by Targeting Cell Division Cycle-Associated Protein 4
por: Zhang, Jiang-Tao, et al.
Publicado: (2021)

CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
por: Gao, Jian, et al.
Publicado: (2018)

RBMS2 Chemosensitizes Breast Cancer Cells to Doxorubicin by Regulating BMF Expression
por: Xu, Feng, et al.
Publicado: (2022)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin
por: Zhu, Hong, et al.
Publicado: (2014)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin
por: Qin, Tao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbtc0vg1v5e7p3hi6nhqtimtis